Literature DB >> 9059139

Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis.

J Tuokko1, H Reijonen, J Ilonen, K Anttila, S Nikkari, T Möttönen, U Yli-Kerttula, A Toivanen.   

Abstract

OBJECTIVE: To study HLA class II association in reactive arthritis.
METHODS: 63 patients with reactive arthritis and 46 with rheumatoid arthritis were included in the study. HLA-DR alleles were determined by using a sequence specific PCR method. Oligonucleotide hybridisation was used for definition of DRB1*04 subtypes and DQB1 alleles. HLA-B27 was determined by standard microcytotoxity test or by PCR. HLA-B27 subtyping was made by sequencing.
RESULTS: 46 (73%) of 63 patients with reactive arthritis were HLA-B27 positive and 24 (38%) were HLA-DRB1*04 positive. When haplotypes were inferred according to the known associations between DRB1 and DQB1 alleles, the frequency of DRB1*04-DQB1*0301 haplotype was found to be 13% (12/92) in HLA-B27 positive reactive arthritis patients, in contrast to 0% in HLA-B27 negative reactive arthritis (P = 0.04) and 1% in random controls (P = 0.0009). However, this combination was also found in 5% of 84 HLA-B27 positive control haplotypes, showing a linkage disequilibrium between B27 and this particular class II haplotype. HLA-DRB1*0408 subtype was found in 8/24 (33%) of the HLA-DRB1*04 alleles in patients with reactive arthritis, accounting for most DQB1*0301 haplotypes, but only in 5/55 (9%) of the DRB1*04 alleles in random controls (P = 0.017). All reactive arthritis patients with this subtype were positive for HLA-B27. DRB1*04-DQB1*0302 haplotype was increased in patients with rheumatoid arthritis (28/92, 30%) compared with reactive arthritis (12/126, 10%) or with the controls (12/100, 12%; P = 0.003). HLA-B*2705 was by far the dominant B27 subtype both in reactive arthritis patients with the particular DRB1*0408-DQB1*0301 haplotype and in controls. It was found in 11 out of 12 DR analysed patients, as well as in 10 out of 11 randomly selected B27 positive controls.
CONCLUSIONS: Although no single class II allele was found to be increased among patients with reactive arthritis, HLA-B27, DRB1*0408, and DQB1*0301 might exert a haplotypic effect in the pathogenesis of reactive arthritis, or they may be markers of a subset of B27 haplotypes conferring susceptibility.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059139      PMCID: PMC1752258          DOI: 10.1136/ard.56.1.37

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

Authors:  O Olerup; H Zetterquist
Journal:  Tissue Antigens       Date:  1992-05

2.  Molecular typing of HLA-B27 alleles.

Authors:  O Dominguez; E Coto; E Martinez-Naves; S Y Choo; C López-Larrea
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  The HLA association with rheumatoid arthritis.

Authors:  J S Lanchbury
Journal:  Clin Exp Rheumatol       Date:  1992 May-Jun       Impact factor: 4.473

Review 4.  Current perspectives in reactive arthritis.

Authors:  G Kingsley; J Sieper
Journal:  Immunol Today       Date:  1993-08

5.  Different DRB1*04 alleles predominate in the Finnish random population and in HLA-B27-positive subpopulations.

Authors:  P Westman; J Partanen; M Leirisalo-Repo; S Koskimies
Journal:  Tissue Antigens       Date:  1994-11

6.  HLA-B27 typing by a group-specific PCR amplification.

Authors:  O Olerup
Journal:  Tissue Antigens       Date:  1994-04

7.  Nomenclature for factors of the HLA system, 1994.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Tissue Antigens       Date:  1994-07

8.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

Authors:  E Hermann; D T Yu; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

9.  Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

Authors:  J D Taurog; S D Maika; W A Simmons; M Breban; R E Hammer
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

10.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  2 in total

1.  Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis.

Authors:  S Laivoranta-Nyman; T Möttönen; R Luukkainen; M Hakala; U Yli-Kerttula; P Hannonen; J Tuokko; A Toivanen; J Ilonen
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Association and frequency of HLA-A, B and HLA-DR genes in south Tunisian patients with spondyloarthritis (SpA).

Authors:  Nadia Mahfoudh; Mariam Siala; Markus Rihl; Arwa Kammoun; Faten Frikha; Hela Fourati; Mohamed Younes; Radhouane Gdoura; Lilia Gaddour; Faiza Hakim; Zouheir Bahloul; Sofien Baklouti; Naceur Bargaoui; Sleheddine Sellami; Adnene Hammami; Hafedh Makni
Journal:  Clin Rheumatol       Date:  2011-03-01       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.